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Smoking exposure is associated with pregnancy complications, as are levels of folate,
vitamin B12, and homocysteine. In nonpregnant adults, smoking exposure is associ-
ated negatively with folate and vitamin B12 levels and positively with homocysteine
levels. A complete overview of the literature on this topic in pregnant women is lack-
ing. To evaluate evidence of associations of maternal smoking exposure during preg-
nancy and levels of folate, homocysteine, and vitamin B12 in pregnancy and in cord
blood, we searched MEDLINE, Embase, CINAHL, Cochrane, Scopus, Web of Science,
and reference lists of relevant studies until August 2017. We selected studies in preg-
nant women describing the association of passive or active smoking and levels of
folate, homocysteine, and/or vitamin B12. Data were extracted by two independent
reviewers. We included 32 studies of 2,015 identified references with a total of
37,822 participants and more than 6,000 smokers. Twenty‐eight studies measured
folate, 14 measured vitamin B12, and 13 measured homocysteine. Nineteen out of
28 studies assessing folate reported significantly lower levels in pregnant women
exposed to smoking compared with those unexposed. Vitamin B12 levels were lower
in smoking mothers in eight out of 14 studies. Homocysteine levels tended to be
higher in mothers exposed to smoking. Smoking exposure during pregnancy is gener-
ally associated with lower folate and vitamin B12 levels and higher homocysteine
levels. This may help raise further awareness about the consequences of smoking
and the need to encourage stopping smoking in all, especially in pregnant women.
KEYWORDS
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Maternal exposure to smoking in pregnancy is associated with a num-
ber of perinatal complications, including miscarriage, placental abrup-
tion, preterm birth, low birthweight, and congenital malformations
(Hackshaw, Rodeck, & Boniface, 2011; Salihu & Wilson, 2007;- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution‐N
ed and is not used for commercial
Published by John Wiley & Sons,U.S. Department of Health and Human Services, 2014).
The mechanisms underlying these associations are not completely
clear. Hypothesized mechanisms include changes in DNA methylation
and vascular changes (Hackshaw et al., 2011; Joubert et al.,
2016; Knopik, Francazio, & McGeary, 2012; Quinton, Cook, & Peek,
2008).- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
onCommercial License, which permits use, distribution and reproduction in any
purposes.
Ltd.
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Key messages
• Smoking exposure during pregnancy still is a challenging
problem for health care professionals and is associated
with pregnancy complications, as are levels of folate,
vitamin B12, and homocysteine.
• A complete overview of literature on the associations of
smoking exposure with folate, vitamin B12, and
homocysteine in pregnant women is lacking.
• We systematically reviewed literature on this topic and
show smoking exposure during pregnancy is generally
associated with lower folate/vitamin B12 levels and
higher homocysteine levels.
• This may help raise further awareness about the
consequences of smoking and the need to encourage
stopping smoking, especially in pregnant women.
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bs_bs_bannerAdequate levels of folate during pregnancy are associated with a
decreased risk of pregnancy complications such as neural tube
defects, preterm delivery, low birthweight, and fetal growth restriction
(Scholl & Johnson, 2000). Vitamin B12 is involved in the same meta-
bolic pathway as folate and has also been associated with a decreased
risk of neural tube defects (Ray & Blom, 2003). Vitamin B12 is a cofac-
tor for methionine synthase, an enzyme that decreases levels of
homocysteine by remethylating it into methionine, with 5‐methyltet-
rahydrofolate as a methyl donor (Ansari, Mahta, Mallack, & Luo,
2014). Thus, low levels of folate or vitamin B12 are associated with
increased homocysteine concentrations, and high homocysteine levels
during pregnancy increase the risk of birth defects and preterm birth
(El‐Khairy, Vollset, Refsum, & Ueland, 2003; Ray & Blom, 2003; Scholl
& Johnson, 2000).
In nonpregnant adults, exposure to smoking is negatively associ-
ated with folate and (Yamada et al., 2013) vitamin B12 levels and pos-
itively associated with homocysteine levels (Mannino, Mulinare, Ford,
& Schwartz, 2003; O'Callaghan, Meleady, Fitzgerald, & Graham, 2002).
A number of studies have examined this association in pregnant
women, but a complete overview of published literature is currently
not available (Bakker, Timmermans, Steegers, Hofman, & Jaddoe,
2011; Bergen et al., 2012; Nilsen et al., 2010; Relton, Pearce, & Parker,
2005; Yamada et al., 2013). Therefore, we aimed to systematically
review the literature evaluating the associations of exposure to
smoking during pregnancy with levels of folate, vitamin B12, and
homocysteine in maternal and cord blood.
2 | METHODS
We carried out a systematic review of studies that evaluated the
associations of exposure to smoking during pregnancy with levels of
folate, vitamin B12, and/or homocysteine in pregnant women and/or
in cord blood. We systematically searched the databases MEDLINE
(via Ovid), Embase (via embase.com), CINAHL (via EBSCOhost),
Cochrane Central (via Wiley), Scopus, and Web of Science for papers
until August 2017. Additional references were retrieved from Google
Scholar and by checking reference lists of retrieved relevant articles.
We used a detailed search strategy combining terms associated with
pregnancy, folate/folic acid, vitamin B12, homocysteine, smoking,
and blood levels (see Appendix S1 for full search strategy). The search
was created by an experienced medical librarian (W. M. B.).
Two independent reviewers (varying pairs of the following
authors: A. T., P. K. B., A. V., A. P., and J. F.) screened the titles and
abstracts of all papers found in the search to decide if they met the
selection criteria. We included cohort studies (prospective and retro-
spective), case–control studies, cross‐sectional studies, randomized
controlled trials (RCTs) or randomized crossover studies. Studies
among pregnant women at any time during pregnancy, reporting any
type and amount of active or second‐hand smoking exposure, and
reporting levels of folate, vitamin B12, homocysteine, or their metabo-
lites in maternal serum/plasma or cord blood were included. We
excluded letters, abstracts, or conference proceedings and studies into
the effect of supplementation. Any disagreements were resolved
through discussion or with the help of a third reviewer. Of the selected
articles, we retrieved full texts, and these were assessed again by twoindependent reviewers. A third reviewer searched the reference lists
of the included articles to detect any additional studies. In case of mul-
tiple publications on the same study population, the most recent paper
or the paper describing the most complete dataset was included.
Data were extracted from the full text papers by two independent
reviewers, using a predefined data collection. The data collection form
contained information on study characteristics (e.g., authors, year of
publication), design and methods (e.g., population characteristics, and
inclusion and exclusion criteria), exposure (e.g., exposure definition
and exposure assessment), outcome (e.g., type of outcome and out-
come assessment), analysis and results (e.g., outcome measures and
covariates), and conclusions. Data extraction of studies in any
language other than English or Dutch was evaluated with the help of
a person fluent in that particular language.
To evaluate the quality of the included studies, we used a
predefined quality score (Leermakers et al., 2015). This quality score
was based on existing scoring systems (Carter, Gray, Troughton,
Khunti, & Davies, 2010; National Collaborating Centre for Methods
and Tools, 2008). Studies received 0, 1, or 2 points on each of five
items: (a) study design: 0 points for cross‐sectional studies, 1 point
for longitudinal studies, and 2 points for intervention studies. (b) Study
size: 0 points if the study population was smaller than 500, 1 point if it
was between 500 and 2,000, and 2 points if it was larger than 2,000.
(c) Exposure assessment: 0 points if the exposure assessment was
inappropriate or not reported, 1 point if exposure assessment was of
moderate quality (e.g., self‐report), and 2 points if exposure measure-
ment was adequate (e.g., marker(s) of smoking in blood). (d) Outcome
assessment: 0 points if no appropriate outcome measurement method
was used or the outcome measurement method was not reported, 1
point if outcome measurement was of moderate quality (e.g., informa-
tion from medical records), and 2 points if outcome measurement was
adequate (e.g., measurement as part of a predefined study protocol
using a standardized method. (e) Statistical adjustments for potential
confounding: 0 points if the findings were not controlled for key con-
founders (pregnancy duration at the time of measurement, a measure
TUENTER ET AL. 3 of 15
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comes), 1 point if controlled for at least these key confounders, and 2
points if controlled for at least two additional covariates out of mater-
nal body mass index, alcohol use, socio‐economic status, maternal age,
and parity. Studies could receive up to a maximum of 10 points, with
10 meaning the highest quality (Table S1).3 | RESULTS
The search strategy identified 2,015 references. On the basis of title
and abstract screening, 1,920 articles were excluded. Of the remaining
95 papers, 63 were excluded on the basis of the full text. The remaining
32 articles are included in this review, as shown in Supplemental S1
(Adaikalakoteswari et al., 2015; Ambroszkiewicz, Chelchowska,
Lewandowski, Gajewska, & Laskowska‐Klita, 2007; Baker et al., 2009;
Bakker et al., 2011; Bergen et al., 2012; Bodnar et al., 2010; Coker
et al., 2011; Dayaldasani et al., 2014; Frery et al., 1992; D. Furness
et al., 2013; D. L. Furness, Yasin, Dekker, Thompson, & Roberts, 2012;
Gadowsky et al., 1995; Hay et al., 2010; Jauniaux, Johns, Gulbis,
Spasic‐Boskovic, & Burton, 2007; Knight et al., 1994; Knudtson et al.,
2004; Larroque et al., 1992; Matsuzaki et al., 2008; McDonald, Perkins,
Jodouin, & Walker, 2002; Mito et al., 2007; Nilsen et al., 2010; Ozerol,
Ozerol, Gokdeniz, Temel, & Akyol, 2004; Pagan, Hou, Goldenberg,
Cliver, & Tamura, 2001; Prasodjo et al., 2014; Relton et al., 2005; Sram,
Binkova, Lnenickova, Solansky, & Dejmek, 2005; Stark et al., 2005;
Stark, Pawlosky, Sokol, Hannigan, & Salem Jr., 2007; Van Uitert et al.,
2014; van Wersch, Janssens, & Zandvoort, 2002; Vandevijvere,
Amsalkhir, Van Oyen, & Moreno‐Reyes, 2012; Yila et al., 2016).
The characteristics of the included articles are shown in Table 1.
Eighteen studies were cohort studies, three were case–control studies,
and 11 studies were cross‐sectional. The 32 studies included a total of
37,822 participants, of whom more than 6,000 smoked (data on the
number of smokers not available for one study; Stark et al., 2005). Indi-
vidual study samples ranged from 33 to 15,266 participants. All studies
were done in Western countries (18 in Europe, nine in North America,
three in Asia, and two in Australia). Quality scores of the included stud-
ies are shown inTable S1. The mean quality score was 4.9, with scores
ranging from 3 to 9. There were no studies receiving the maximum
amount of 2 points for study design, as there were no studies with
an interventional study design. Seven out of 32 studies received the
maximum of 2 points for appropriate exposure measurement, and out-
come measurement was done adequately in 30 out of 32 studies.
Twenty‐eight studies measured folate or its metabolites, 14
reported on vitamin B12, and 13 measured homocysteine. Two stud-
ies included participants from the same study population, with one
focusing on maternal blood levels and one on cord blood levels. Thus,
we included data on maternal folate levels from the earlier paper and
umbilical cord blood levels from the later paper (Stark et al., 2005;
Stark et al., 2007).3.1 | Associations of maternal smoking exposure and
folate levels
Table 2 shows the results of the 28 studies measuring levels of folate
or its metabolites in a total of 30,938 participants (Adaikalakoteswariet al., 2015; Ambroszkiewicz et al., 2007; Baker et al., 2009; Bergen
et al., 2012; Bodnar et al., 2010; Coker et al., 2011; D. Furness et al.,
2013; D. L. Furness et al., 2012; Gadowsky et al., 1995; Hay et al.,
2010; Jauniaux et al., 2007; Knight et al., 1994; Larroque et al.,
1992; Matsuzaki et al., 2008; McDonald et al., 2002; Mito et al.,
2007; Nilsen et al., 2010; Ozerol et al., 2004; Pagan et al., 2001;
Prasodjo et al., 2014; Relton et al., 2005; Sram et al., 2005; Stark
et al., 2005; Stark et al., 2007; Van Uitert et al., 2014; van Wersch
et al., 2002; Vandevijvere et al., 2012; Yila et al., 2016). Twenty‐six
studies measured folate levels in maternal blood (serum, plasma, or
erythrocytes) and seven studies measured folate levels in umbilical
cord blood. All studies in maternal blood showed negative associations
of smoking exposure with folate levels, which were significant in 71%
(n = 20) of the studies. The study with the highest quality score (9)
showed odds ratios of 1.20 (95% CI [1.10–1.31]) and 1.91 (95% CI
[1.70–2.14]) for passive and active smoking, respectively, for having
a suboptimal folate status. Apart from this study, four other studies
used cotinine (Jauniaux et al., 2007; Nilsen et al., 2010; Prasodjo
et al., 2014) or thiocyanate (Pagan et al., 2001) levels to assess
smoking exposure. Three of these studies showed significant negative
associations of smoking with maternal folate levels (Jauniaux et al.,
2007; Nilsen et al., 2010; Pagan et al., 2001). In the study measuring
thiocyanate levels, only the difference at 30 weeks' gestational age
was significant with a P value of <0.005 (Pagan et al., 2001). One
study divided the participants with increased cotinine levels into
passive and active smokers. No significant association of smoking
exposure with folate levels was found in either group (Prasodjo
et al., 2014).
Three other studies described the association of maternal expo-
sure to passive smoking with folate levels (Sram et al., 2005; Stark
et al., 2005; Yila et al., 2016). Two of these reported a significantly
negative association (Stark et al., 2005).
Seven studies measured folate levels in umbilical cord blood.
One of these found a significant negative association (lower levels)
of smoking with umbilical cord blood levels of folate (Stark et al.,
2007). The other six studies did not report significant associations
(Adaikalakoteswari et al., 2015; Ambroszkiewicz et al., 2007; Coker
et al., 2011; Hay et al., 2010; Relton et al., 2005; Sram et al., 2005).
One study described serum levels of folate during pregnancy
measured at four different time points (0–10, 11–20, 21–30, and
31–40 weeks; van Wersch et al., 2002). At all time points, the associ-
ation was negative, reaching statistical significance at the three latest
time points.
One study did not report tobacco smoke exposure, but smoking
of marihuana (Knight et al., 1994). This study found a significant neg-
ative correlation (r = −0.25, P value = 0.02) of smoking marihuana with
maternal folate levels.
Figure 1a shows a harvest plot of the studies assessing the
association of maternal smoking with folate levels. The harvest plots
display the associations found and the corresponding quality scores
of the studies. One study did not report information on significance
and is therefore not presented in the harvest plot (Sram et al., 2005).
If a study measured folate levels at different time points, the
results of the latest time point were used for the harvest plot. If
folate metabolites were measured in different components of blood
TABLE 1 Summary of the 32 studies included in this review that studied the association between exposure to smoking during pregnancy levels
of folate, vitamin B12, and homocysteine
First author (year) Study setting Outcome measuresa Study design Total N
Mean age
(year)
Quality
score
Adaikalakoteswari (2015) United Kingdom Folate, homocysteine,
vitamin B12
Cross‐sectional 91 32.7 3
Ambroszkiewicz (2007) Poland Folate, homocysteine Cross‐sectional 57 Median:
s: 26
ns: 32
4
Baker (2009) United Kingdom Folate, cobalamin Prospective cohort 306 Range: 14–18 6
Bakker (2011) The Netherlands Homocysteine Prospective cohort 6,294 29.9 8
Bergen (2012) The Netherlands Folate, homocysteine,
vitamin B12
Prospective cohort 5,805 29.8 6
Bodnar (2010) United States Folate Prospective cohort 313 <20: 12%
22–29: 73%
≥30: 15%
4
Coker (2011) Turkey Folate, homocysteine Prospective cohort 58 s: 26.1
ns: 27.1
5
Dayaldasani (2014) Spain Vitamin B12 Prospective cohort 204 30 5
Frery (1992) France Vitamin B12 Cross‐sectional 188 29.2 4
D. Furness (2013) Australia Folate, homocysteine,
vitamin B12
Prospective cohort 137 33 4
D. L. Furness (2012) Australia Folate Retrospective
case–control
400 24.8 3
Gadowsky (1995) Canada Folate, homocysteine,
vitamin B12
Cross‐sectional 58 17.0 3
Hay (2010) Norway Folate, homocysteine,
cobalamin
Retrospective cohort 340 29.9 6
Jauniaux (2007) United Kingdom Folate Cross‐sectional 125 nm 4
Knight (1994) United States Folate, vitamin B12 Prospective cohort 87 Range: 16–35 5
Knudtson (2004) United States Homocysteine Case–control 198 Cases: 25
Controls: 24
4
Larroque (1992) France Folate Prospective cohort 245 ≤22: 25%
23–29: 43%
≥30: 32%
4
Matsuzaki (2008) Japan Folate Cross‐sectional 537 30.5 4
McDonald (2002) Canada Folate, homocysteine,
vitamin B12
Cross‐sectional 80 s: 24.0
ns: 26.2
4
Mito (2007) Japan Folate Cross‐sectional 70 29.9 4
Nilsen (2010) Norway Folate Prospective cohort 2,934 29.8 8
Ozerol (2004) Turkey Folate, homocysteine,
vitamin B12
Cross‐sectional 33 nm 3
Pagan (2001) United States Folate, homocysteine,
vitamin B12
Prospective cohort 196 25.5 5
Prasodjo (2014) Canada/United
States
Folate Prospective cohort 362 18–25: 23%
25–35: 60%
≥35: 17%
7
Relton (2005) United Kingdom Folate, vitamin B12 Prospective cohort 998 27.8 5
Sram (2005) Czech Republic Folate Case–control 766 nm 5
Stark (2005) United States 5‐MTHFA Prospective cohort 116 24.5 6
Stark (2007) United States 5‐MTHFA Prospective cohort 58 24.8 6
Van Uitert (2014) The Netherlands Folate Prospective cohort 77 32.7 4
Van Wersch (2002) The Netherlands Folate, homocysteine,
vitamin B12
Cross‐sectional 138 nm 3
Vandevijvere (2012) Belgium Folate Cross‐sectional 1,285 28.5 ≤ 19: 1% 6
Yila (2016) Japan Folate Prospective cohort 15,266 <20: 1%
20–24: 12%
25–29: 31%
30–34: 37%
≥35: 19%
9
Note. 5‐MTHFA: 5‐methyltetrahydrofolic acid; nm: not mentioned; ns: nonsmokers; s: smokers.
aNomenclature as in original paper.
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bs_bs_banner(plasma/serum/red blood cells), the measurement most comparable
with that of the other studies was presented in the harvest plot.3.2 | Associations of maternal smoking exposure and
vitamin B12 levels
Table 3 shows the results of the 13 studies measuring vitamin B12
levels in a total of 8,661 participants. The mean quality score was
4, and quality scores ranged from 3 to 6. Eleven studies reported
lower levels of vitamin B12 in smokers, of which seven were signif-
icant (Adaikalakoteswari et al., 2015; Baker et al., 2009; Bergen
et al., 2012; Dayaldasani et al., 2014; Frery et al., 1992; D. Furness
et al., 2013; Gadowsky et al., 1995; Hay et al., 2010; Knight et al.,
1994; McDonald et al., 2002; Ozerol et al., 2004; Pagan et al.,
2001; Relton et al., 2005; vanWersch et al., 2002) The study assessing
smoking using thiocyanate levels found significantly lower levels of
vitamin B12 in smoking compared with nonsmoking mothers at two
time points in pregnancy (Pagan et al., 2001). The study assessing the
effect of marihuana smoking during pregnancy did not find a correla-
tion with vitamin B12 levels (Knight et al., 1994). One of the four stud-
ies reporting measurements in umbilical cord blood showed a
significant difference between the levels of vitamin B12 in smoking
and nonsmoking pregnant women, with lower levels of vitamin B12
in women exposed to smoking (Adaikalakoteswari et al., 2015; Frery
et al., 1992; Hay et al., 2010; Relton et al., 2005). The results of
the associations of maternal smoking with levels of vitamin B12 are
presented in Figure 1b.3.3 | Associations of maternal smoking exposure and
homocysteine levels
The results of the 13 studies reporting on homocysteine levels in a
total of 13,485 participants are shown in Table 4. Quality scores
ranged from 3 to 8 points, and three studies received a quality score
of more than 5 points. In maternal blood, out of 12 studies, five
studies showed significantly higher levels of homocysteine in pregnant
women exposed to smoking (Adaikalakoteswari et al., 2015;
Ambroszkiewicz et al., 2007; Bakker et al., 2011; Bergen et al., 2012;
Coker et al., 2011; D. Furness et al., 2013; Gadowsky et al., 1995;
Knudtson et al., 2004; McDonald et al., 2002; Ozerol et al., 2004;
Pagan et al., 2001; van Wersch et al., 2002). The study measuring
thiocyanate levels in blood as an objective measure of smoking
exposure found higher levels of homocysteine in smokers as com-
pared with nonsmokers, but this difference was nonsignificant
(Pagan et al., 2001). The study with the highest quality score showed
significantly higher homocysteine levels in smoking women compared
with nonsmoking women with smoking being associated with a
0.05 unit increase in log‐transformed homocysteine levels (95% CI
[0.03–0.06]; Bakker et al., 2011). Four studies used umbilical cord
blood measurements (Adaikalakoteswari et al., 2015; Ambroszkiewicz
et al., 2007; Coker et al., 2011; Hay et al., 2010), of which two showed
a significant positive association of smoking with homocysteine levels
(Ambroszkiewicz et al., 2007; Coker et al., 2011). Figure 1c shows
harvest plots of the associations of maternal smoking and homocyste-
ine levels.
(a)
(b)
(c)
FIGURE 1 (a–c) Harvest plots of the evidence for associations of smoking with folate, vitamin B12, and homocysteine levels. One study
did not report information on significance and is therefore not presented in the harvest plot (Sram et al., 2005). * indicates associations
were determined at different time points in pregnancy. If there were discrepancies in the significance between the time points, the plot
represents the significance of the measurement of the latest time point. † indicates levels of folate were measured in different blood
components (e.g., maternal plasma, serum, or red blood cells). If there were discrepancies in the significance between the components, the plot
represents the significance of the measurement most comparable with the measurements of the other studies (Table 2). The study of
Gadowsky et al. measured levels of folate in maternal plasma and red blood cells; results of maternal RBC are shown. The study of Larroque
et al. measure levels of folate in maternal serum and maternal RBC; results of maternal serum are shown. ‡ indicates significance was
determined using different statistical tests. If there were discrepancies in the significance between tests, only the significance of the regression
analysis is shown
TUENTER ET AL. 9 of 15
bs_bs_banner4 | DISCUSSION
4.1 | Main findings
Our systematic review shows that levels of both folate and vitamin
B12 were lower in blood samples of pregnant women exposed to
smoking than in blood samples of pregnant women who were not
exposed to smoking. The same association was generally seen in cord
blood, but the number of studies measuring cord blood levels waslower (eight out of 32 studies), and there were fewer significant asso-
ciations. Homocysteine levels tended to be higher in maternal and
cord blood of pregnant women exposed to smoking.4.2 | Interpretation of results
Low folate and vitamin B12 levels and high homocysteine levels
during pregnancy are associated with poor perinatal outcomes
(Mannino et al., 2003; Nelen, Blom, Steegers, den Heijer, & Eskes,
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bs_bs_banner2000; O'Callaghan et al., 2002; Ray & Blom, 2003; Scholl & Johnson,
2000). Folate and vitamin B12 are important regulators of homocyste-
ine levels. Decreased levels of folate and vitamin B12 cause an
increase in homocysteine, because both micronutrients are cofactors
in the methylation of homocysteine to methionine (Refsum, Ueland,
Nygard, & Vollset, 1998).
A number of mechanisms may underlie the negative associations
of smoking exposure with folate and vitamin B12 levels and the
positive associations with homocysteine levels. Firstly, several compo-
nents of cigarette smoke, such as organic nitrites, nitrous oxide,
cyanates, and isocyanates, can increase oxidative stress and interact
with folate and vitamin B12, causing these micronutrients to become
inactive (Northrop‐Clewes & Thurnham, 2007). This leads to lower
levels of folate and vitamin B12 and higher levels of homocysteine.
Secondly, nicotine use can lead to a change in basal metabolic rate
by increasing serum levels of catecholamines (Walker et al., 1999).
This leads to higher nutritional demands in smokers, which are already
increased during pregnancy (Picciano, 2003).
A third pathway that can cause lower micronutrient levels in
smokers is a difference in diet between smokers and nonsmokers
(Dallongeville, Marecaux, Fruchart, & Amouyel, 1998). It is not
completely clear what causes the difference in dietary preferences
of smokers as compared with nonsmokers. Hypotheses include a
reduction of monoamine oxidase in smokers, leading to changes in
mood and appetite, a direct influence of nicotine on taste receptors,
and a generally unhealthier lifestyle (Dallongeville et al., 1998; Leroy
et al., 2009). Differences in dietary habits may have larger effects in
pregnancy, when the nutritional demands are different (King, 2000;
Picciano, 2003). Previous work has shown that the association
of maternal smoking with low birthweight may be modified by
periconceptional folic acid supplementation, underlining the interac-
tive effects of these exposures on fetal growth (Bakker et al., 2011).4.3 | Strengths and limitations
The quality of the studies included in this review varied widely, as
reflected in the quality scores. In some studies, a low score was mainly
given because of a small number of participants, but there also was
room for improvement in assessing exposure status with more
objective measures. Not all studies adjusted for key confounders such
as dietary intake, supplementation, maternal age, and duration of
gestation at the time of measurement of the outcome. Due to the
large diversity in study designs and reporting of measures of associa-
tion, it was not possible to include a meta‐analysis of the individual
study results.
As smoking during pregnancy is generally considered a socially
undesired habit, pregnant women may report a lower amount of ciga-
rettes smoked or not having smoked at all, which can lead to
misclassification of the exposure. Therefore, we cannot comment on
a possible dose–effect association of smoking with nutrient levels.
The majority of studies assessed smoking exposure by questionnaire,
and only five studies used cotinine or thiocyanate blood levels to
objectively determine smoking exposure (Jauniaux et al., 2007; Nilsen
et al., 2010; Pagan et al., 2001; Prasodjo et al., 2014; Yila et al., 2016).
The results of these studies were in line with those measuring smoking
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bs_bs_bannerexposure by questionnaire, with lower levels of folate and vitamin
B12 and higher levels of homocysteine. If anything, the misclassifica-
tion that can occur by using questionnaires would bias results
towards the null, as it is unlikely that misclassification would occur in
the opposite direction (i.e., overreporting of smoking habits in preg-
nant women).
In theory, the association of smoking exposure with micronutrient
levels would ideally be assessed using an RCT, but this would raise
important ethical issues. All studies in this review are cohorts or
case–control studies, which are the best options for this specific
research question.
The total number of participants in all studies combined was
37,822, which is substantial, but there was a large range in study sizes,
with the smallest study consisting of 33 participants (Ozerol et al.,
2004) and the largest of 15,266 participants (Yila et al., 2016).5 | CONCLUSION
In general, smoking was associated with lower levels of folate and
vitamin B12 and higher levels of homocysteine in maternal blood, with
the strongest evidence for folate. This may help raise further aware-
ness about the consequences of smoking and the need to encourage
stopping smoking in all, especially in pregnant women. Also, they
may highlight a potential need for more intense and targeted advice
about supplementation of mainly folic acid to pregnant women,
depending on smoking status.
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